OpenScience.ink

3 weeks ago • European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society

GLP-1 receptor agonists and recovery results after neck spine fusion surgery: a review and analysis of real-world dataGLP-1 receptor agonists and outcomes after cervical spine fusion: a systematic review, meta-analysis, and evidence map of real-world evidence.

📖 Top 20% JournalArticle

3 weeks ago • Diabetes, obesity & metabolism

Predicting who responds to GLP-1 or GLP-1/GIP receptor agonist treatmentsResponders Vs. Non-Responders or How to Predict the Response to GLP-1 or GLP-1/GIP Receptor Agonist Therapy.

Article

3 weeks ago • Bioscience trends

How GLP-1 receptor drugs may change immune and metabolism functions in people with HIVImmunometabolic reprogramming via GLP-1 receptor agonists in people with HIV: A multidimensional systemic framework.

📖 Top 20% JournalArticle

3 weeks ago • JAR life

Effects of GLP-1 receptor drugs on adult skeletal muscle and what this means for older adultsGLP-1 receptor agonist therapy and skeletal muscle: A narrative review synthesizing adult evidence with implications for older adults.

Article

4 weeks ago • Frontiers in clinical diabetes and healthcare

Cost comparison of liraglutide and sitagliptin for type 2 diabetes not well controlled by metforminEconomic evaluation of liraglutide versus sitagliptin in the treatment of type 2 diabetes mellitus inadequately controlled with metformin.

📖 Top 30% JournalArticle

4 weeks ago • Obesity science & practice

Healthcare Professionals’ Views on Injectable GLP-1 Medicines for Treating ObesityAttitudes Toward Injectable GLP-1 Drugs for Obesity Treatment: A Qualitative Interview Study With Healthcare Professionals.

📖 Top 30% JournalArticle

4 weeks ago • iScience

Comparing semaglutide, tirzepatide, and retatrutide on kidney scarring in blocked and old miceComparative effects of semaglutide tirzepatide and retatrutide on renal fibrosis in UUO and aged mice.

🎖️ Top 10% JournalArticle

4 weeks ago • Advances in therapy

How Blood Sugar Treatments Relate to Memory and Thinking Loss: From Biological Processes to Patient Studies and Future DirectionsGlucose-Lowering Therapies and Cognitive Decline: From Molecular Mechanisms to Clinical Evidence and Future Perspectives.

📖 Top 20% JournalArticle

4 weeks ago • Frontiers in urology

Comparing glucagon-like peptide-1 receptor drugs and other diabetes medicines in prostate cancer patients receiving hormone therapyGlucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy.

Article

4 weeks ago • Obesity reviews : an official journal of the International Association for the Study of Obesity

Updating Worldwide Obesity Guidelines by Combining Evidence, Fairness, and Personalized Approaches (2014-2026)Rethinking Global Obesity Guidelines: Integrating Evidence, Equity and Precision (2014-2026).

Article

4 weeks ago • npj metabolic health and disease

Rethinking obesity treatment with new GLP-1 receptor drugsReappraising obesity management in the GLP-1 receptor agonist era.

Letter

4 weeks ago • Naunyn-Schmiedeberg's archives of pharmacology

Mental health and eye problems linked to use of GLP-1 receptor drugsPsychiatric and eye disorders associated with use of glucagon-like peptide 1 receptor agonists (GLP-1 RAs).

📖 Top 30% JournalArticle

4 weeks ago • Appetite

Genetic differences in GLP-1 signaling may influence appetite control in preadolescentsInteraction among GLP-1 signaling-related genetic variants suggests contribution to the control of appetitive traits among preadolescents.

📖 Top 20% JournalArticle

4 weeks ago • Food research international (Ottawa, Ont.)

Bifidobacterium breve i1088 postbiotic may help type 2 diabetes by boosting GLP-1 hormone through 5-hydroxyindoleacetic acidPostbiotic of Bifidobacterium breve i1088 alleviates type 2 diabetes by promoting GLP-1 secretion: identification of 5-hydroxyindoleacetic acid as a key active metabolite.

🎖️ Top 10% JournalArticle

4 weeks ago • Diabetes care

Heart and Metabolism Effects of Drugs Targeting Both GLP-1 and Glucagon ReceptorsCardiometabolic Effects of Dual GLP-1 and Glucagon Receptor Agonists: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Article

4 weeks ago • The lancet. Diabetes & endocrinology

Mazdutide's safety and effectiveness in US adults with obesity or overweight: a phase 2 clinical trialEfficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

🥇 Top 1% JournalArticle

4 weeks ago • Science advances

A small oral drug that affects energy and fat metabolism to treat obesity and related conditionsA multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

🥈 Top 2% JournalArticle

4 weeks ago • World journal of clinical pediatrics

Current and upcoming medicines for treating obesity in teenagers: Evidence-based reviewCurrent and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review.

📖 Top 20% JournalArticle

← prevpage 13 of 14next →

Latest GLP-1 Therapies Research Papers